Universe Pharmaceuticals Inc (UPC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 09/30
(Values in U.S. thousands)
| 09-2025 | 09-2024 | 09-2023 | 09-2022 | 09-2021 | |
| Sales | 17,859 | 23,025 | 32,309 | 40,143 | 47,982 |
| Cost of Goods | 11,558 | 16,953 | 21,994 | 18,252 | 22,656 |
| Gross Profit | 6,301 | 6,072 | 10,315 | 21,891 | 25,326 |
| Operating Expenses | 9,775 | 15,044 | 15,275 | 29,582 | 12,392 |
| Operating Income | -2,916 | -8,020 | -3,966 | -7,439 | 13,590 |
| Interest Expense | 232 | 278 | 157 | 162 | 102 |
| Other Income | -524 | 177 | -205 | -383 | 190 |
| Pre-tax Income | -3,672 | -8,121 | -4,327 | -7,984 | 13,679 |
| Income Tax | N/A | 607 | 2,254 | 752 | 2,359 |
| Net Income Continuous | -3,672 | -8,727 | -6,581 | -8,737 | 11,320 |
| Net Income | $-3,672 | $-8,727 | $-6,581 | $-8,737 | $11,320 |
| EPS Basic Total Ops | -8.06 | -626.96 | -1,089.21 | -1,445.28 | 2,158.49 |
| EPS Basic Continuous Ops | -8.06 | -626.96 | -1,089.21 | -1,445.33 | 2,145.48 |
| EPS Diluted Total Ops | -8.06 | -626.96 | -1,089.21 | -1,445.28 | 2,158.49 |
| EPS Diluted Continuous Ops | -8.06 | -626.96 | -1,089.21 | -1,445.33 | 2,145.48 |
| EPS Diluted Before Non-Recurring Items | -8.06 | -626.96 | -1,019.49 | -1,438.99 | 2,158.49 |
| EBITDA(a) | $-2,399 | $-7,534 | $-3,457 | $-6,905 | $14,037 |